These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10945009)

  • 1. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cancer cooperative groups in Japan.
    Fukuda H
    Jpn J Clin Oncol; 2010 Sep; 40(9):881-90. PubMed ID: 20670961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the Japan Clinical Oncology Group].
    Ohe Y; Saijo N
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1127-32. PubMed ID: 10945006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy].
    Shimoyama M
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):235-46. PubMed ID: 9987525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improving the infrastructure for clinical trials in Japan].
    Nakano S
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement.
    Blessing JA; Bialy SA; Whitney CW; Stonebraker BL; Stehman FB
    Clin Trials; 2010 Aug; 7(4):390-9. PubMed ID: 20576671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials].
    Shimoyama M; Tajima K
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2507-18. PubMed ID: 8279849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
    Dilts DM; Sandler AB
    J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance issues in conducting multi-institutional advanced technology clinical trials.
    Purdy JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S66-70. PubMed ID: 18406941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An essential partnership: patient advocates and cooperative groups.
    Collyar D
    Semin Oncol; 2008 Oct; 35(5):553-5. PubMed ID: 18929153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site visit monitoring program of the clinical cooperative groups: results of the first 3 years.
    Mauer JK; Hoth DF; Macfarlane DK; Hammershaimb LD; Wittes RE
    Cancer Treat Rep; 1985 Oct; 69(10):1177-87. PubMed ID: 4042096
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality assessment and assurance programs in the Gynecologic Oncology Group.
    Stehman FB; Blessing JA; Fowler WC; Park RC
    Obstet Gynecol; 1994 Dec; 84(6):1059-62. PubMed ID: 7970467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality control in clinical trials].
    Fukushima M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):172-82. PubMed ID: 8611045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.